Status:
UNKNOWN
Efficacy of Moxibustion in Diabetes Peripheral Neuropathy
Lead Sponsor:
Xiamen University
Conditions:
Peripheral Neuropathy
Diabetic Neuropathies
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This pragmatic randomized controlled study aimed to evaluate the effectiveness and safety of moxibustion therapy on diabetes peripheral neuropathy.
Detailed Description
Background: The purpose of this study is to investigate the clinical effects of moxibustion for treating diabetes peripheral neuropathy. Hypothesis: Subjects who have participated in the moxibustion ...
Eligibility Criteria
Inclusion
- All patients between 18 and 75 years with diagnosed diabetes mellitus, according to WHO criteria.
- Proven peripheral neuropathy.
- Written consent with documentation that all participants received relevant information about this study is given to the patient.
- The participants must be willing and able to meet the planned visit and meet the planned schedule, including participation in the experimental investigations.
Exclusion
- Health professionals' assessment makes the patient have medical or surgical diseases unsuitable to participate in the study.
- Pregnancy or breastfeeding for female patients.
- Competitive conditions that can cause peripheral neuropathy.
- Participants involved in the planning or execution of the study.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04894461
Start Date
November 1 2021
End Date
December 30 2023
Last Update
May 20 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.